G1 Therapeutics (GTHX) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

G1 Therapeutics (GTHX) Stock Forecast for 2024–2028. Sell or Buy?

Updated: June 24, 2024 (02:30)

Sector: Healthcare

The share price of G1 Therapeutics, Inc. (GTHX) now

Latest session on the 21st of June for
G1 Therapeutics, Inc. is negative
Trading Volume: 687654
Open: 2.52 /  High: 2.58 /  Low: 2.37
What analysts predict: $8.5
52-week High/Low: $6.14 / $1.08

50/200 Day Moving Average: $3.882 / $2.929

This figure corresponds to the Average Price over the previous 50/200 days. For G1 Therapeutics stocks, the 50-day moving average is the resistance level today.

For G1 Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in G1 Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the G1 Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one G1 Therapeutics share be worth in 2024 - 2028?

When should I take profit in G1 Therapeutics stock? When should I record a loss on G1 Therapeutics stock? What are analysts' forecasts for G1 Therapeutics stock? What is the future of G1 Therapeutics stock? We forecast G1 Therapeutics stock performance using neural networks based on historical data on G1 Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

G1 Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for G1 Therapeutics shares. This happens once a day.


Historical and forecast chart of G1 Therapeutics stock

The chart below shows the historical price of G1 Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the G1 Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

G1 Therapeutics, Inc. is a clinical biopharmaceutical company that develops and delivers innovative treatments that improve the lives of people with cancer.

Official site of the company

G1 Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 25 2.44 2.41 2.49 3.45
Jun 26 2.40 2.35 2.42 2.85
Jun 27 2.40 2.37 2.46 3.68
Jun 28 2.42 2.34 2.45 4.79
Jun 29 2.41 2.36 2.44 3.22
Jun 30 2.46 2.39 2.51 5.09
Jul 01 2.44 2.39 2.49 3.96
Jul 02 2.41 2.33 2.46 5.37
Jul 03 2.32 2.28 2.38 4.53
Jul 04 2.32 2.27 2.38 5.11
Jul 05 2.23 2.17 2.28 5.02
Jul 06 2.21 2.19 2.28 4.21
Jul 07 2.25 2.23 2.31 3.59
Jul 08 2.22 2.20 2.26 2.62
Jul 09 2.17 2.14 2.20 2.92
Jul 10 2.19 2.15 2.24 4.24
Jul 11 2.15 2.13 2.22 4.16
Jul 12 2.12 2.10 2.14 2.02
Jul 13 2.12 2.10 2.17 3.56
Jul 14 2.16 2.11 2.19 3.94
Jul 15 2.17 2.12 2.23 5.16
Jul 16 2.09 2.03 2.14 5.51
Jul 17 2.07 2.01 2.12 5.18
Jul 18 2.03 2.00 2.07 3.45
Jul 19 2.09 2.03 2.14 5.01
Jul 20 2.16 2.10 2.20 4.45
Jul 21 2.15 2.13 2.21 3.72
Jul 22 2.18 2.15 2.24 4.09
Jul 23 2.14 2.12 2.17 2.38
Jul 24 2.10 2.07 2.12 2.02

G1 Therapeutics Daily Price Targets


G1 Therapeutics Stock Forecast 06-25-2024.

Forecast target price for 06-25-2024: $2.44.
Negative dynamics for G1 Therapeutics shares will prevail with possible volatility of 3.336%.
Pessimistic target level: 2.41
Optimistic target level: 2.49

G1 Therapeutics Stock Forecast 06-26-2024.

Forecast target price for 06-26-2024: $2.40.
Negative dynamics for G1 Therapeutics shares will prevail with possible volatility of 2.772%.
Pessimistic target level: 2.35
Optimistic target level: 2.42

G1 Therapeutics Stock Forecast 06-27-2024.

Forecast target price for 06-27-2024: $2.40.
Positive dynamics for G1 Therapeutics shares will prevail with possible volatility of 3.551%.
Pessimistic target level: 2.37
Optimistic target level: 2.46

G1 Therapeutics Stock Forecast 06-28-2024.

Forecast target price for 06-28-2024: $2.42.
Positive dynamics for G1 Therapeutics shares will prevail with possible volatility of 4.572%.
Pessimistic target level: 2.34
Optimistic target level: 2.45

G1 Therapeutics Stock Forecast 06-29-2024.

Forecast target price for 06-29-2024: $2.41.
Negative dynamics for G1 Therapeutics shares will prevail with possible volatility of 3.118%.
Pessimistic target level: 2.36
Optimistic target level: 2.44

G1 Therapeutics Stock Forecast 06-30-2024.

Forecast target price for 06-30-2024: $2.46.
Positive dynamics for G1 Therapeutics shares will prevail with possible volatility of 4.844%.
Pessimistic target level: 2.39
Optimistic target level: 2.51

GTHX (GTHX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jul. 3.08 2.54 3.32 23.54
Aug. 3.45 2.92 4.19 30.26
Sep. 3.41 2.77 3.73 25.90
Oct. 3.05 2.68 3.27 17.91
Nov. 2.67 2.18 2.83 23.13
Dec. 2.33 1.84 2.81 34.42

G1 Therapeutics forecast for this year


G1 Therapeutics Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $3.07594. Pessimistic: $2.54. Optimistic: $3.32


G1 Therapeutics Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $3.44967. Pessimistic: $2.92. Optimistic: $4.19


G1 Therapeutics Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $3.41241. Pessimistic: $2.77. Optimistic: $3.73


G1 Therapeutics Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $3.05309. Pessimistic: $2.68. Optimistic: $3.27


G1 Therapeutics Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $2.66565. Pessimistic: $2.18. Optimistic: $2.83


G1 Therapeutics Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $2.32738. Pessimistic: $1.84. Optimistic: $2.81



G1 Therapeutics (GTHX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 2.25 1.77 2.54 30.59
Feb 2.22 2.04 2.57 20.54
Mar 1.93 1.58 2.28 30.71
Apr 2.39 2.17 2.85 23.84
May 1.81 1.44 2.03 28.82
Jun 1.91 1.57 2.29 31.66
Jul 2.20 1.75 2.46 28.79
Aug 2.63 2.17 3.15 30.97
Sep 2.81 2.24 3.41 34.49
Oct 3.03 2.43 3.38 28.24
Nov 3.61 3.37 4.19 19.52
Dec 3.65 3.11 4.27 27.06

G1 Therapeutics (GTHX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 4.08 3.62 4.55 20.56
Feb 3.86 3.08 4.16 26.04
Mar 4.10 3.74 4.63 19.12
Apr 4.13 3.60 4.79 24.92
May 3.93 3.33 4.23 21.34
Jun 3.74 3.38 4.21 19.89
Jul 4.37 3.61 5.27 31.59
Aug 5.49 4.49 5.89 23.66
Sep 5.31 4.91 6.02 18.56
Oct 5.05 4.52 5.81 22.28
Nov 5.47 4.59 6.39 28.22
Dec 4.11 3.31 4.46 25.66

G1 Therapeutics (GTHX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 3.49 2.75 4.16 33.99
Feb 3.10 2.78 3.26 14.86
Mar 2.87 2.31 3.45 33.01
Apr 3.10 2.65 3.64 27.17
May 3.31 2.77 3.64 24.06
Jun 3.55 3.22 3.79 15.18
Jul 3.32 3.03 3.62 16.36
Aug 3.80 3.13 4.40 28.88
Sep 4.11 3.26 4.74 31.12
Oct 3.36 2.69 3.61 25.42
Nov 3.08 2.47 3.53 29.93
Dec 2.94 2.42 3.38 28.21

G1 Therapeutics (GTHX) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 2.65 2.30 3.03 24.15
Feb 2.81 2.40 3.06 21.57
Mar 2.83 2.58 3.31 21.92
Apr 2.99 2.60 3.17 18.05
May 3.26 2.79 3.68 24.20
Jun 2.86 2.59 3.44 24.70
Jul 3.06 2.72 3.28 17.16
Aug 3.83 3.58 4.64 22.97
Sep 3.80 3.41 4.35 21.49
Oct 3.54 3.14 4.22 25.77
Nov 3.77 2.96 4.16 28.82
Dec 3.55 3.34 4.07 17.91

G1 Therapeutics information and performance

G1 Therapeutics Address

79 T.W. ALEXANDER DRIVE, 4501 RESEARCH COMMONS, SUITE 100, RESEARCH TRIANGLE PARK, NC, US

Market Capitalization: 129 658 000 $

Market capitalization of the G1 Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GTHX shares in the company outstanding by the market price of one share.

EBITDA: -22 328 000 $

EBITDA of G1 Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.6

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.118
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.56

Enterprise Value (EV) /Revenue

EV To EBITDA: -6.16

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 52281000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.